MAXWELLIA logo — Widening access to medicines

MAXWELLIA

Widening access to medicines

Founded 2013 United Kingdom Alderley Edge, United Kingdom 10 employees Unknown Total: $5.50M Biopharma, Health Care +1

General Information

Company Name MAXWELLIA
Founded Year 2013
Location United Kingdom Alderley Edge, United Kingdom +2
Employees 10
Industries Biopharma, Health Care, Pharmaceutical
Funding Stage Unknown
Social

Get notified when MAXWELLIA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MAXWELLIA

Maxwellia is a pioneering British start-up in the biopharma, health care, and pharmaceutical industries. Founded in 2013, Maxwellia's unique proposition lies in converting prescription medicines into versions available for purchase in pharmacies. The company's dedication to facilitating the safe supply of medicines under the supervision of pharmacists sets it apart. Their innovative approach aims to alleviate the burden on general practitioners by enabling individuals to manage certain conditions without the need for a doctor's appointment. With a vision to widen access to a range of widely used and effective medicines, Maxwellia's mission revolves around making these products conveniently available in local pharmacies, thus reducing the strain on an over-stretched NHS. The latest Venture Round investment in Maxwellia occurred on October 6, 2021, and the investors behind this funding round are not specified. As Maxwellia continues to innovate and develop breakthrough products, its impact in transforming the accessibility of healthcare products and services will be one to watch.

Taxonomy: pharmaceuticals, over-the-counter drugs, MHRA, women's health, prescription drugs, medicine reclassification, health products, drug accessibility, public consultation, OTC market, pharmaceutical regulation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Late Vc £1.10M - 01 Jun 2025
Late Vc Unknown 5 01 Dec 2022
Media For Equity Unknown 1 01 Oct 2021
Early VC €3.70M 5 01 Apr 2021
Grant Unknown - 01 Jul 2020

View All 7 Funding Rounds

MAXWELLIA Alternatives & Competitors

MAXWELLIA vs
Hello Alpha
Hello Alpha United States

The virtual, on-demand women’s health platform offering inclusive, whole-person care for women at ev...

Series B
90 employees
Health Care, Information Technology
MAXWELLIA vs

India Ki Pharmacy

Series C
1589 employees
E-Commerce, Health Care
MAXWELLIA vs
Market Foresight
Market Foresight United States

Driving Smart Decisions™

2 employees
Analytics, Health Care

FAQ About MAXWELLIA

Widening access to medicines
MAXWELLIA was founded in 2013.
MAXWELLIA is headquartered in Alderley Edge, United Kingdom.
MAXWELLIA operates in the following industries: Biopharma, Health Care, Pharmaceutical.
MAXWELLIA has approximately 10 employees.
MAXWELLIA has completed 7 funding rounds, raising a total of $5.50M. The latest funding stage is Unknown.
Top alternatives and competitors to MAXWELLIA include Hello Alpha, Netmeds.com, Market Foresight, Cadence OTC, Generic Village . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MAXWELLIA and Hello Alpha are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MAXWELLIA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy